Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-26 @ 12:54 AM
NCT ID:
NCT03941834
Pre Assignment Details:
Out of 65 participants, only 30 were randomized in DBT phase, and 35 participants were not randomized (screen failure \[28\], sponsor decision \[1\], medical monitor decision \[1\], physician decision \[1\], withdrawal of consent \[4\]).
Recruitment Details:
There were 2 phases in the study: double blind treatment (DBT) phase followed by open label extension (OLE) phase. Participants after completing DBT phase could enter OLE phase if the Principal Investigator (PI) believed open-label treatment offered an acceptable risk-benefit profile. A total of 65 participants with refractory trigeminal neuralgia (TN) were enrolled in the study.
Study:
NCT03941834
Study Brief:
Results Section:
NCT03941834